Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

510.38
-5.0800-0.99%
Volume:538.52K
Turnover:275.07M
Market Cap:21.89B
PE:18.26
High:515.55
Open:510.95
Low:507.03
Close:515.46
52wk High:609.35
52wk Low:375.61
Shares:42.89M
Float Shares:39.35M
Volume Ratio:1.27
T/O Rate:1.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.42
PE(LYR):18.32

Loading ...

United Therapeutics announces retirement of Professor Dwek from board

TIPRANKS
·
Apr 29

Earning Preview: United Therapeutics this quarter’s revenue is expected to increase by 9.51%, and institutional views are bullish

Earnings Agent
·
Apr 29

United Therapeutics director Raymond Dwek retires from board, term ends June 26, 2026

Reuters
·
Apr 29

United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.b.e., F.r.s., From Its Board of Directors

THOMSON REUTERS
·
Apr 29

United Therapeutics CEO Martine Rothblatt disposes of 10,500 shares worth $5.99 million

Reuters
·
Apr 29

United Therapeutics CFO James Edgemond disposes of shares worth $5.32 million

Reuters
·
Apr 29

Analysts’ Opinions Are Mixed on These Healthcare Stocks: United Therapeutics (UTHR), Insmed (INSM) and MannKind (MNKD)

TIPRANKS
·
Apr 28

United Therapeutics CEO Martine Rothblatt disposes of shares worth $5.37 million

Reuters
·
Apr 28

United Therapeutics CFO James Edgemond sells 10,000 shares for $5.72 million

Reuters
·
Apr 25

United Therapeutics director Christopher Patusky sells 2,910 shares for $1.66 million

Reuters
·
Apr 25

United Therapeutics Corp : RBC Raises Target Price to $707 From $700

THOMSON REUTERS
·
Apr 24

United Therapeutics CEO Martine Rothblatt disposes 9,500 shares worth $5.5 million

Reuters
·
Apr 24

United Therapeutics CEO Martine Rothblatt disposes of shares worth $5.3 million

Reuters
·
Apr 23

Press Release: United Therapeutics Corporation to Report First Quarter 2026 Financial Results Before Market Open on Wednesday, May 6, 2026

Dow Jones
·
Apr 22

United Therapeutics to report first-quarter results, host webcast before market open

Reuters
·
Apr 22

United Therapeutics CFO James Edgemond disposes of shares worth $5,715,739.33

Reuters
·
Apr 21

United Therapeutics CEO Martine Rothblatt disposes of shares worth $4,902,773

Reuters
·
Apr 21

United Therapeutics says ARTISAN interim data show early high-dose treprostinil improves PAH heart function

Reuters
·
Apr 20

United Therapeutics director Christopher Patusky sells USD 578,880 common shares

Reuters
·
Apr 18

United Therapeutics CEO Martine Rothblatt disposes 9,500 shares for $5.49 million

Reuters
·
Apr 18